Bruker Corporation Stock

Equities

BRKR

US1167941087

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 04:00:00 2024-06-13 pm EDT 5-day change 1st Jan Change
65.09 USD -1.69% Intraday chart for Bruker Corporation +0.22% -11.42%
Sales 2024 * 3.4B Sales 2025 * 3.67B Capitalization 9.85B
Net income 2024 * 310M Net income 2025 * 420M EV / Sales 2024 * 3.17 x
Net Debt 2024 * 900M Net Debt 2025 * 554M EV / Sales 2025 * 2.83 x
P/E ratio 2024 *
31.4 x
P/E ratio 2025 *
24.2 x
Employees 9,707
Yield 2024 *
0.31%
Yield 2025 *
0.31%
Free-Float 56.63%
More Fundamentals * Assessed data
Dynamic Chart
Transcript : Bruker Corporation Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-12-2024 11:20 AM
Transcript : Bruker Corporation Presents at Jefferies 2024 Global Healthcare Conference, Jun-06-2024 07:30 AM
Bruker Corporation Launches Ultimate Sensitivity timsTOF Ultra 2 to Enable New Research Paradigms in Single-Cell and Subcellular Proteomics CI
Bruker Corporation Launches Transformative neofleX? MALDI-TOF System for Spatial Biology Mass Spec Imaging Applications CI
Bruker Prices Offering of 6 Million Shares MT
Bruker Shares Fall Following Public Offering of 6 Million Shares MT
Stifel Adjusts Price Target on Bruker to $77 From $81, Maintains Hold Rating MT
Transcript : Bruker Corporation - Special Call
Bruker Keeps Quarterly Dividend at $0.05 Per Share; Payable June 17 to Shareholders of Record on June 3 MT
Bruker Corporation Announces Quarterly Dividend, Payable on June 17, 2024 CI
Bruker's NanoString Secures Patent Case Win in Germany MT
Bruker Corporation completed the acquisition of Substantially all assets from NanoString Technologies, Inc. (OTCPK:NSTG.Q), NanoString Technologies Germany GmbH, Nanostring Technologies International, Inc. and NanoString Technologies Netherlands B.V. CI
Bruker Shares Fall After Q1 Revenue Misses Consensus Views; Lifts Full-Year Guidance MT
Transcript : Bruker Corporation, Q1 2024 Earnings Call, May 02, 2024
Earnings Flash (BRKR) BRUKER CORPORATION Posts Q1 Revenue $721.7M, vs. Street Est of $729M MT
More news
1 day-1.69%
1 week+0.22%
Current month-0.64%
1 month-12.32%
3 months-29.71%
6 months-10.17%
Current year-11.42%
More quotes
1 week
63.44
Extreme 63.44
66.49
1 month
63.09
Extreme 63.09
79.78
Current year
63.09
Extreme 63.09
94.86
1 year
53.79
Extreme 53.79
94.86
3 years
48.42
Extreme 48.42
94.86
5 years
30.78
Extreme 30.78
94.86
10 years
15.78
Extreme 15.778
94.86
More quotes
Managers TitleAgeSince
Chief Executive Officer 64 91-01-31
Director of Finance/CFO 66 16-11-30
Public Communications Contact - 10-09-30
Members of the board TitleAgeSince
Director/Board Member 66 15-08-18
Director/Board Member 77 00-01-31
Director/Board Member 67 15-11-10
More insiders
Date Price Change Volume
24-06-13 65.09 -1.69% 1,139,453
24-06-12 66.21 +2.60% 1,130,410
24-06-11 64.53 -0.63% 771,393
24-06-10 64.94 +0.37% 1,276,360
24-06-07 64.7 -0.38% 1,948,488

Delayed Quote Nasdaq, June 13, 2024 at 04:00 pm EDT

More quotes
Bruker Corporation is a developer, manufacturer and distributor of scientific instruments and analytical and diagnostic solutions. Its BSI BioSpin segment designs, manufactures, and distributes enabling life science tools based on magnetic resonance technology. Its BSI CALID segment designs, manufactures and distributes life science mass spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments and solutions. Its BSI Nano segment designs, manufactures and distributes advanced X-ray instruments, atomic force microscopy instrumentation, advanced fluorescence optical microscopy instruments. Its Bruker Energy & Supercon Technologies (BEST) segment develops and manufactures superconducting and non-superconducting materials and devices for use in renewable energy, energy infrastructure, healthcare and big science research. It also offers advanced research Raman microscopy systems. Its product lines include nCounter, CosMx, GeoMx and AtoMx.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
65.09 USD
Average target price
82.67 USD
Spread / Average Target
+27.01%
Consensus